GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) » Definitions » Cyclically Adjusted PS Ratio

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Cyclically Adjusted PS Ratio : 2.18 (As of Jun. 03, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted PS Ratio?

As of today (2025-06-03), Shanghai Fosun Pharmaceutical (Group) Co's current share price is HK$16.00. Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was HK$7.33. Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PS Ratio for today is 2.18.

The historical rank and industry rank for Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

HKSE:02196' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.89   Med: 5.13   Max: 10.49
Current: 2.08

During the past years, Shanghai Fosun Pharmaceutical (Group) Co's highest Cyclically Adjusted PS Ratio was 10.49. The lowest was 1.89. And the median was 5.13.

HKSE:02196's Cyclically Adjusted PS Ratio is ranked better than
51.22% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.13 vs HKSE:02196: 2.08

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shanghai Fosun Pharmaceutical (Group) Co's adjusted revenue per share data for the three months ended in Mar. 2025 was HK$3.830. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is HK$7.33 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted PS Ratio Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.27 5.66 3.52 2.28 2.08

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.05 1.93 2.35 2.08 2.04

Competitive Comparison of Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PS Ratio falls into.


;
;

Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=16.00/7.33
=2.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Shanghai Fosun Pharmaceutical (Group) Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.83/115.1156*115.1156
=3.830

Current CPI (Mar. 2025) = 115.1156.

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 1.678 99.500 1.941
201509 1.633 100.500 1.870
201512 1.796 100.600 2.055
201603 1.639 102.200 1.846
201606 1.928 101.400 2.189
201609 1.845 102.400 2.074
201612 1.860 102.600 2.087
201703 1.837 103.200 2.049
201706 2.033 103.100 2.270
201709 2.176 104.100 2.406
201712 2.632 104.500 2.899
201803 2.816 105.300 3.078
201806 3.063 104.900 3.361
201809 2.692 106.600 2.907
201812 3.014 106.500 3.258
201903 3.094 107.700 3.307
201906 3.253 107.700 3.477
201909 3.122 109.800 3.273
201912 3.177 111.200 3.289
202003 2.592 112.300 2.657
202006 3.418 110.400 3.564
202009 3.607 111.700 3.717
202012 3.772 111.500 3.894
202103 3.743 112.662 3.825
202106 4.213 111.769 4.339
202109 4.724 112.215 4.846
202112 5.788 113.108 5.891
202203 5.048 114.335 5.082
202206 4.976 114.558 5.000
202209 4.326 115.339 4.318
202212 5.174 115.116 5.174
202303 4.642 115.116 4.642
202306 4.363 114.558 4.384
202309 3.627 115.339 3.620
202312 4.239 114.781 4.251
202403 4.162 115.227 4.158
202406 4.149 114.781 4.161
202409 4.234 115.785 4.210
202412 4.153 114.893 4.161
202503 3.830 115.116 3.830

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shanghai Fosun Pharmaceutical (Group) Co  (HKSE:02196) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Fosun Pharmaceutical (Group) Co Business Description

Traded in Other Exchanges
Address
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers mergers and acquisitions as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.
Executives
Blackrock, Inc. 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.
Shanghai Fosun High Technology (group) Co., Ltd.
Fosun International Holdings Ltd. 2201 Interest of corporation controlled by you
Fosun International Limited 2101 Beneficial owner
Guo Guangchang 2201 Interest of corporation controlled by you

Shanghai Fosun Pharmaceutical (Group) Co Headlines

No Headlines